For the first time, breast cancer has overtaken lung cancer as the most commonly occurring malignancy globally, according to the World Health Organization (WHO). As stated in a UN briefing ahead of World Cancer Day 2021 by Dr Andre Ilbawi, a cancer specialist, breast cancer now accounts for nearly 12% of new cancer cases each […]

The American Society of Clinical Oncology (ASCO) Clinical Cancer Advances 2021 report, published in February, highlights current trends in oncology and identifies cancer research priorities. A key focus of this year’s report is the issue of health equity in cancer research and solutions. While tremendous progress has been made in cancer prevention, early detection, and […]

Current reports estimate that by 2030, approximately 12 million people diagnosed with cancer will be older than 70 years. Many older adults with cancer have multimorbidity and their health status can vary greatly. Therefore, treatment decisions based solely on chronologic age may put some older patients at risk for undertreatment or overtreatment. Comprehensive geriatric assessment […]

Immune checkpoint inhibitors (ICIs) have had a rapid and broad expansion of their indications in recent months and are now the standard of care for many types of cancer. ICIs promote an antitumor immune response by inhibiting cytotoxic T-lymphocyte antigen-4 (CTLA-4), programmed cell death protein 1 /ligand 1 (PD-1/PD-L1), or both. However, this mechanism of […]

Digital features in medical publications are here to stay. These features offer unique benefits that make reading and sharing easier, and less time-consuming. If your organization has been slow to integrate digital features in medical publications, you may be missing out. Read on to learn more about the benefits of digitally enhanced medical publications. Digital Tools […]

The emergence of COVID-19 has substantially disrupted delivery of cancer care, with postponements and cancellations of surgeries, as well as delays in systemic and radiotherapies. For patients with slow-growing tumors, these delays may be safe, but for others, waiting to start treatment can have a negative impact on outcomes. The benefits and risks of immediate […]

Measurable (formerly minimal) residual disease, or MRD, refers to low levels of leukemia that cannot be detected by morphologic assessment alone. While not a new concept in the management of patients with leukemias, MRD testing in the management of acute myeloid leukemia (AML) has recently gained increased attention among disease-state experts. In a large-cohort meta-analysis […]

In 2020, COVID-19 had only a minimal effect on drug approvals, which were considerably higher in comparison with 2019. The US Food and Drug Administration (FDA) approved more than 50 new medicines and therapeutic biologics in 2020, more than a third of which were oncology/hematology treatments. Similarly, the European Medicines Agency’s Committee for Medicinal Products […]

Since the outbreak of COVID-19, telehealth has emerged as a way to continue patient care while minimizing risk of virus exposure. Interestingly, telehealth visits are not always on a screen. Many patients—particularly those who are older or have lower incomes—prefer to communicate with their providers via telephone over video visits. When parts of the US […]

Pancreatic cancer is one of the most difficult malignancies to manage. Multiple factors contribute to poor survival in these patients, including delayed diagnosis, rapid progression to metastatic disease, pain, and blood clots, all of which can complicate care. Outcomes have improved in recent decades, yet the current 5-year survival rate is still only 9%. The […]